Literature DB >> 11555728

Ankylosing spondylitis and undifferentiated spondyloarthropathies: a clinical review and description of a disease subset with older age at onset.

I Olivieri1, C Salvarani, F Cantini, G Ciancio, A Padula.   

Abstract

The onset of ankylosing spondylitis, as defined by the currently used criteria, after the age of 50 years is uncommon. Late-onset undifferentiated spondyloarthropathy is relatively more frequent. Its clinical spectrum seems to be as wide as it is in children and young and middle-aged adults. Most patients have two or more manifestations of spondyloarthropathy and meet the Amor criteria or the European Spondylarthropathy Study Group criteria. Some patients show only one manifestation of the B27-associated disease process for years and need more sensitive criteria. A subset of patients shows distal inflammatory swelling with pitting edema on the dorsum of feet or hands together with peripheral arthritis and peripheral enthesitis. In these cases spondyloarthropathy must be differentiated from other inflammatory rheumatic diseases with elderly onset showing the same distal inflammatory swelling with pitting edema.

Entities:  

Mesh:

Year:  2001        PMID: 11555728     DOI: 10.1097/00002281-200107000-00006

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  13 in total

Review 1.  Ankylosing spondylitis: introductory comments on its diagnosis and treatment.

Authors:  M A Khan
Journal:  Ann Rheum Dis       Date:  2002-12       Impact factor: 19.103

2.  Presumptive Late-Onset Ankylosing Spondylitis Simulating Osteoblastic Skeletal Metastasis in a Patient With a History of Prostate Carcinoma: A Diagnostic Challenge.

Authors:  Charles P Fischer; Peter C Emary; John A Taylor
Journal:  J Chiropr Med       Date:  2015-11-19

3.  Fat-suppression magnetic resonance imaging in the diagnosis of late-onset axial spondyloarthropathy.

Authors:  Sateesh Shankaranarayana; Ai Lyn Tan; Julie Madden; Dennis McGonagle
Journal:  Ann Rheum Dis       Date:  2007-10       Impact factor: 19.103

Review 4.  Spondyloarthritis with onset after age 45.

Authors:  Ignazio Olivieri; Salvatore D'Angelo; Angela Padula; Pietro Leccese; Carlo Palazzi
Journal:  Curr Rheumatol Rep       Date:  2013-12       Impact factor: 4.592

5.  Assessment of efficacy of pamidronate in undifferentiated spondyloarthropathy (uSpA): a placebo control trial in a tertiary level center.

Authors:  Rathindra Nath Sarkar; Sibaji Phaujdar; Dibyendu De; Kuntal Bhattacharyya
Journal:  Rheumatol Int       Date:  2011-12-27       Impact factor: 2.631

Review 6.  Management issues with elderly-onset rheumatoid arthritis: an update.

Authors:  Ignazio Olivieri; Carlo Palazzi; Giovanni Peruz; Angela Padula
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 7.  Late-onset ankylosing spondylitis and related spondylarthropathies: clinical and radiological characteristics and pharmacological treatment options.

Authors:  Eric Toussirot; Daniel Wendling
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

8.  Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial.

Authors:  J Braun; J Zochling; X Baraliakos; R Alten; G Burmester; K Grasedyck; J Brandt; H Haibel; M Hammer; A Krause; F Mielke; H-P Tony; W Ebner; B Gömör; J Hermann; H Zeidler; E Beck; M Baumgaertner; J Sieper
Journal:  Ann Rheum Dis       Date:  2006-04-10       Impact factor: 19.103

9.  Study of bone mineral density in patients with ankylosing spondylitis.

Authors:  Hatinder Jeet Singh; Kaur Nimarpreet; Sibadatta Das; Ashok Kumar; Shesh Prakash
Journal:  J Clin Diagn Res       Date:  2013-12-15

Review 10.  Elderly onset rheumatoid arthritis: differential diagnosis and choice of first-line and subsequent therapy.

Authors:  Juan Ignacio Villa-Blanco; Jaime Calvo-Alén
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.